The compatibility of oxytocin and tranexamic acid injection
products when mixed for co-administration by infusion for the treatment
of postpartum haemorrhage: an in vitro investigation
Pete Lambert1, Alessandra
Tomazzini2, Philip Wright1, Claire
McEvoy1, Ioannis Gallos3, Anne
Ammerdorffer2, Lester Chinery2, Arri
Coomarasamy3, A. Metin Gülmezoglu2
1 Drug Delivery Disposition and Dynamics, Monash
Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC,
3052, Australia2 Concept Foundation, Bâtiment F2F3, Avenue de
Sécheron 15, Geneva, 1202, Switzerland.3 Institute of Metabolism and Systems Research (IMSR),
WHO Collaborating Centre for Global Women’s Health Research, University
of Birmingham, Birmingham, UK
Corresponding author
A. Metin Gülmezoglu, Concept Foundation, Bâtiment F2F3, Avenue de
Sécheron 15, Geneva, 1202, Switzerland,
gulmezoglum@conceptfoundation.org,
+41 22 734 2560/1
Running title
Oxytocin and tranexamic acid products mixed for co-administration